Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 91.13% is in line with its 5-year average of 93.99%, near the low end of its 5-year range (88.85%–98.59%).
0.23% below its 12-month average of 91.34%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 90.81%.
GROSS MARGIN
91.13%
GROSS MARGIN AVG TTM
91.34%
GROSS MARGIN AVG 3Y
91.59%
GROSS MARGIN AVG 5Y
93.99%
GROSS MARGIN AVG 10Y
93.68%
GROSS MARGIN AVG 15Y
90.78%
GROSS MARGIN AVG 20Y
95.42%
CURRENT VS TTM AVG
-0.23%
CURRENT VS 3Y AVG
-0.50%
CURRENT VS 5Y AVG
-3.04%
CURRENT VS 10Y AVG
-2.72%
CURRENT VS 15Y AVG
+0.38%
CURRENT VS 20Y AVG
-4.50%
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
+112.37%
vs the sector median at left
Acadia Pharmaceuticals Inc.
Market Cap
$3.44B
Gross Margin
91.13%
TTM Avg
91.34%
3Y Avg
91.59%
5Y Avg
93.99%
Market Cap
$3.62B
Gross Margin
-43.89%
TTM Avg
0.67%
3Y Avg
45.02%
5Y Avg
61.14%
Market Cap
$3.25B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.16B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
50.00%
5Y Avg
66.67%
Market Cap
$3.15B
Gross Margin
91.14%
TTM Avg
90.25%
3Y Avg
87.92%
5Y Avg
58.61%
Market Cap
$3.09B
Gross Margin
0.00%
TTM Avg
25.88%
3Y Avg
57.90%
5Y Avg
-575.35%
Market Cap
$2.88B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc. (ACAD) | $3.44B | 91.13% | 91.34% | 91.59% | 93.99% |
| Celcuity Inc. (CELC)vs › | $3.59B | 0.00% | 0.00% | 0.00% | 0.00% |
| CareDx, Inc (CDNA)vs › | $3.61B | 70.58% | 67.35% | 65.86% | 66.29% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.62B | -43.89% | 0.67% | 45.02% | 61.14% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | 0.00% | 0.00% | 0.00% | 0.00% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | 0.00% | 0.00% | 50.00% | 66.67% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 91.14% | 90.25% | 87.92% | 58.61% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | 0.00% | 25.88% | 57.90% | -575.35% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 0.00% | 0.00% | 0.00% | 0.00% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 58.69% | 59.64% | 63.22% | 64.62% |
Gross Margin
91.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 90.81% |
| 2026-03-31 | 90.75% |
| 2025-12-31 | 90.77% |
| 2025-09-30 | 92.23% |
| 2025-06-30 | 92.16% |
| 2025-03-31 | 91.65% |
| 2024-12-31 | 91.60% |
| 2024-09-30 | 92.47% |
| 2024-06-30 | 92.47% |
| 2024-03-31 | 88.85% |
| 2023-12-31 | 92.26% |
| 2023-09-30 | 93.09% |
| 2023-06-30 | 95.49% |
| 2023-03-31 | 98.59% |
| 2022-12-31 | 98.23% |
| 2022-09-30 | 98.37% |
| 2022-06-30 | 98.02% |
| 2022-03-31 | 97.45% |
| 2021-12-31 | 98.04% |
| 2021-09-30 | 94.92% |
| 2021-06-30 | 95.48% |
| 2021-03-31 | 95.60% |
| 2020-12-31 | 95.62% |
| 2020-09-30 | 96.02% |
| 2020-06-30 | 95.03% |
| 2020-03-31 | 94.48% |
| 2019-12-31 | 94.58% |
| 2019-09-30 | 95.04% |
| 2019-06-30 | 94.00% |
| 2019-03-31 | 92.73% |
| 2018-12-31 | 92.63% |
| 2018-09-30 | 90.78% |
| 2018-06-30 | 91.10% |
| 2018-03-31 | 92.87% |
| 2017-12-31 | 91.50% |
| 2017-09-30 | 90.97% |
| 2017-06-30 | 89.48% |
| 2017-03-31 | 80.78% |
| 2016-12-31 | 80.67% |
| 2016-09-30 | 74.94% |
| 2016-06-30 | -697.94% |
| 2016-03-31 | -569275.00% |
| 2015-12-31 | -134994.12% |
| 2015-09-30 | -47923.08% |
| 2015-06-30 | -1837800.00% |
| 2015-03-31 | -407275.00% |
| 2014-12-31 | -38585.11% |
| 2014-09-30 | -112913.33% |
| 2014-06-30 | -49182.14% |
| 2014-03-31 | -38793.33% |
| 2013-12-31 | -21318.92% |
| 2013-09-30 | -2922.50% |
| 2013-06-30 | -1476.94% |
| 2013-03-31 | -962.35% |
| 2012-12-31 | -1189.74% |
| 2012-09-30 | -26.51% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 100.00% |
| 2003-03-31 | 100.00% |
